Redsense Medical announces that Peter Larsson is taking over as CFO, as Jennie Kardell decided to leave the company to pursue other opportunities. Peter Larsson will be joining the team as part-time CFO consultant.

Peter Larsson, born in 1969, has held multiple leading positions as CFO and CEO for a variety of companies across industries and geographies, including listed companies across markets. He has over 30 years of experience as CFO and a proven track record in scaling healthcare and technology companies. http://www.linkedin.com/in/peter-larsson/3843b835/

"We are thrilled that Peter is joining Redsense and are looking forward to a great cooperation. With extensive experience in MedTech and financial leadership, he brings a wealth of expertise to the team. We also thank Jennie Kardell for her contributions as both CFO and interim-CEO, and wish her the best of luck in her future endeavours" says Sebastien Bollue, CEO of Redsense Medical AB.

The company will also have additional support from a Postdoc intern from Karolinska Institute and a master student from Halmstad University, who will both assist the company on a part-time basis. Redsense participated in Karolinska Institute’s Internship Program HT24, and hired a part-time Postdoc who is assisting the company during 6 months in health economics research, communication, and regulatory affairs. The program is co-financed by Karolinska Institute career services and Redsense. The part-time master student from Halmstad University will also assist with commercial operations such as supply chain management, quality management, and sustainability issues.

"We are excited to welcome our new team members; their expertise will strengthen our operations and support our continued growth. We remain committed to advancing Redsense and creating lasting value."

— Sebastien Bollue, CEO of Redsense Medical AB.

Contact information

For more information, please contact: 
Sebastien Bollue, CEO
Telephone: +46 72-171 1264
E-mail: sebastien.bollue (at) redsensemedical.com

Redsense Medical AB (publ), 556646-4862

About Redsense Medical

Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector. The Redsense Medical share is listed on Spotlight Stock Market (REDS).